换一批An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcoma.
第一作者：
J T,Hartmann
第一单位：
Department of Medical Oncology, Hematology, Immunology, Rheumatology, Pneumology, South West German Cancer Center, Eberhard-Karls-University, Tuebingen, Germany. joerg.hartmann@med.uni-tuebingen.de
作者：
医学主题词
成年人(Adult);老年人(Aged);抗代谢药, 抗肿瘤(Antimetabolites, Antineoplastic);脱氧胞苷(Deoxycytidine);无病生存(Disease-Free Survival);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);肉瘤(Sarcoma);软组织肿瘤(Soft Tissue Neoplasms)
DOI
10.1007/s10637-005-3537-1
PMID
16133789
发布时间
2022-12-07
- 浏览6
Investigational new drugs
249-53页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
